Fiduciary Duty of Care

The fiduciary duty of care is a director’s obligation to be reasonably informed and deliberate before making decisions that affect the corporation. It does not require perfect knowledge or flawless choices, but it does demand that directors gather material information, ask difficult questions, and think before voting.

What the duty entails

The duty of care is fundamentally procedural. A director satisfies it by taking steps to become informed before voting. This means attending board meetings, reviewing materials provided, asking questions of management, consulting advisers when appropriate, and thinking through the consequences of a decision. If a board is approving a merger, the care duty demands that directors study the target company, understand the terms, review fairness opinions or valuation analyses, and deliberate on synergies and risks. A director cannot simply rubber-stamp management’s recommendation without inquiry.

Care does not require that the director be correct. Markets are uncertain; judgment calls have genuine downside risk. A director who carefully considers an acquisition that later fails to deliver promised synergies has still satisfied the duty of care. What matters is the quality of the process, not the eventual commercial outcome.

Nor does care require unanimity. Directors often disagree, vote against a proposal, and lose. The duty is individual: each director must personally satisfy themselves through their own inquiry. A director can participate in a process, ask tough questions, dissent from a decision, and still satisfy the duty of care—indeed, vocal dissent on a matter may strengthen the record.

The “prudent person” standard

Most statutes articulate the duty as requiring the care a prudent person would exercise in a similar position under similar circumstances. This is an objective standard, not a subjective one. The law does not ask whether a particular director personally would have chosen the same course. It asks whether the director’s process and deliberation met a reasonable standard.

The law also accounts for context. A director reviewing a routine vendor contract can satisfy the duty with less scrutiny than a director considering a merger that will reshape the company. A director acting on a matter within their own expertise (a financial officer evaluating a capital project, a technology expert assessing a systems upgrade) might be held to a higher standard of knowledge than a director in an unfamiliar domain. Most courts recognise that directors can reasonably rely on management experts, board committees, and external advisers—so long as they do so thoughtfully rather than blindly.

Procedural safeguards and informed boards

Many boards protect themselves against care duty breaches by adopting robust governance procedures. These include requiring materials to be distributed before meetings, holding committee discussions before full-board votes, obtaining outside opinions on major transactions, and documenting their process. A merger approval that includes management presentations, third-party fairness opinions, legal advice, and strategic discussion creates a paper trail that demonstrates care.

Board committees—audit, compensation, nominating, strategic—function partly as care mechanisms. Delegating a matter to a committee with expertise and allowing that committee to do its work fulfils the care duty more thoroughly than a full board handling every issue without specialisation. A director on the compensation committee who reviews executive pay proposals with the committee’s adviser, attends meetings, and asks questions about methodology has taken care. A director who skips those meetings and votes yes at the full board has not.

The rise of environmental, social, and governance (ESG) considerations has expanded care duties in some cases. Directors now face pressure to be informed about the company’s climate risks, supply-chain practices, and governance gaps. Failing to understand material ESG risks that could affect market capitalization or earnings may constitute failure of the care duty.

When care duty is breached

A director breaches the duty of care by voting on a significant matter without adequate information. Examples include: attending a board meeting sporadically and voting without reading materials; pushing a deal forward without independent due diligence; ignoring red flags raised by management or advisers; or failing to ask questions when information is incomplete. A director who delegates all responsibility for a matter to management without personal inquiry may breach the duty, especially on high-stakes decisions.

Some breaches are egregious: a director who votes on an acquisition they did not read the terms of, or who votes without even attending the meeting. Others are subtler: a director who attended the meeting and reviewed materials but failed to probe an obvious inconsistency in the valuation. Courts apply a reasonableness test, asking whether the director acted as a prudent person would have.

Relationship to the business judgment rule

The care duty and the business judgment rule work in tandem. If a director satisfies the care duty (is reasonably informed, acts in good faith, and has no conflict), the business judgment rule presumes the decision was proper and shields the director from liability even if the business outcome was poor. If the director fails the care duty—was not reasonably informed, or was reckless—the presumption may be rebutted and the director faces liability.

This means the care duty is both a substantive obligation and, practically, a shield. Directors who comply with it gain the protection of the business judgment rule. Directors who do not comply lose that protection and may be held liable for losses flowing from their negligent decision.

Modern pressures and evolving standards

Activist investors and proxy advisors now closely examine board process and scrutinise whether directors are truly engaged. A board that approves a stock buyback without visible strategic discussion, or that approves executive compensation with minimal deliberation, may face shareholder challenge on grounds that the care duty was not satisfied.

At the same time, some argue that heightened scrutiny of process has made board service more onerous and has pushed directors toward excessive risk aversion. Directors now sometimes demand more and more analyses before voting, out of fear of care-duty litigation. Others contend that modern directors have access to far more information than their predecessors and should therefore be held to a correspondingly higher standard of diligence.

The most common outcome is that the care duty has become contextual. For routine matters, courts and practitioners accept lighter-touch processes. For transformative transactions—sales, mergers, major recapitalisations—the bar for care is higher, and boards are expected to spend time, solicit advice, and document their reasoning.

See also